Home » Sepracor Drug Lunesta Fails in Anxiety Trial
Sepracor Drug Lunesta Fails in Anxiety Trial
Sepracor Inc. said that its insomnia drug Lunesta did not reach its main goal in a clinical trial that tested it as a treatment for generalized anxiety disorder.
BusinessWeek
BusinessWeek
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May